Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-16

FDA Approved: BUDESONIDE INHALATION SUSPENSION — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Budesonide Inhalation Suspension from Cipla USA Inc., confirming regulatory approval of this generic inhaled cortico…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide Inhalation Suspension (budesonide)

Snippet

SUPPL AP for BUDESONIDE INHALATION SUSPENSION (BUDESONIDE)